Bortezomib
FDA Approved: * November 6, 2017Pharm Company: * FRESENIUS KABI USA
Category: Cancer
Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.[1] This includes multiple myeloma in those who have and have not previously received treatment.[2] It is generally used together with other medications.[2] It is given by injection.[1] Common side effects include nausea, diarrhea, tiredness, low platelets, fever, numbness, low white blo... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 0143-9098
Labeler:
Hikma Pharmaceuticals USA Inc.
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 0409-1700
Labeler:
Hospira, Inc.
Bortezomib 2.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 0409-1703
Labeler:
Hospira, Inc.
Bortezomib 1 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 0409-1704
Labeler:
Hospira, Inc.
Bortezomib 3.5 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0781-3258
Labeler:
Sandoz Inc
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 10019-991
Labeler:
Baxter Healthcare Corporation
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 25021-244
Labeler:
Sagent Pharmaceuticals
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 43598-426
Labeler:
Dr.reddy's Laboratories, Inc.
Bortezomib 3.5 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 43598-865
Labeler:
Dr.reddy's Laboratories Inc
Bortezomib 3.5 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 50742-484
Labeler:
Ingenus Pharmaceuticals, LLC
Related Brands
Drugs with the same active ingredientsPopular Topics
gabantin-Bortezomib induced peripheral neuropathy(BINP)
I am a multiple myeloma patient, undergone 3 cycles of chemotherapy with bortezomib,and undergone autologus bonemarrow t...
1 REPLY